Abstract | BACKGROUND: METHODS: The expression levels of IL-17 were examined among 60 patients with LC. Immunofluorescence colocalization experiments were performed to verify the localization of IL-17 and FAS/FASL in Hep-2 and Tu212 cells. The role of IL-17 was determined using siRNA techniques in the LC cell line. RESULTS: In the LC patients, cytokines were dysregulated in LC tissues compared with normal tissues. It was found that IL-17 was overexpressed in a cohort of 60 LC tumors paired with nontumor tissues. Moreover, high IL-17 expression was significantly associated with the advanced T category, the late clinical stage, differentiation, lymph node metastasis, and recurrence. In addition, the time course expression of FAS and FASL was observed after stimulation and treatment with the IL-17 stimulator. Finally, in vitro experiments demonstrated that IL-17 functioned as an oncogene by inhibiting the apoptosis of LC cells via the PI3K/AKT/FAS/FASL pathways. CONCLUSIONS: In summary, these findings demonstrated for the first time the role of IL-17 as a tumor promoter and a prometastatic factor in LC and indicated that IL-17 may have an oncogenic role and serve as a potential prognostic biomarker and therapeutic target in LC.
|
Authors | Yang Song, Ming Yang, Hongjian Zhang, Yan Sun, Ye Tao, Huihui Li, Jing Zhang, Yuncheng Li, Jianming Yang |
Journal | Journal of immunology research
(J Immunol Res)
Vol. 2020
Pg. 2953191
( 2020)
ISSN: 2314-7156 [Electronic] Egypt |
PMID | 33415169
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Yang Song et al. |
Chemical References |
- Cytokines
- Fas Ligand Protein
- Interleukin-17
- fas Receptor
- Proto-Oncogene Proteins c-akt
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Apoptosis
(genetics, immunology)
- Cell Line, Tumor
- Cytokines
(metabolism)
- Disease Progression
- Fas Ligand Protein
(metabolism)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Immunomodulation
(genetics)
- Interleukin-17
(genetics, metabolism)
- Laryngeal Neoplasms
(genetics, metabolism, pathology)
- Lymphocyte Activation
(genetics, immunology)
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Staging
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- ROC Curve
- Signal Transduction
- T-Lymphocytes
(immunology, metabolism)
- Young Adult
- fas Receptor
(metabolism)
|